Connor Evans

Research Fellow in Evidence Synthesis. Neurodiverse. Christian 🙏 Lover of food, running 🏃and indoor plant enthusiast 🪴🌿

[Connor Evans @ConnorJEvans]

So proud to be part of this team - truly amazing work! And the REFoRMS spin-offs just keep coming!

[REFoRMS Project @REFoRMS_Rhabdo]

We are so proud to have been able to share some of the latest spin-off projects from the Living-REFoRMS programme of work at this years #SIOPCongress @WorldSIOP ✅

(It's also the first time the full team have all been in the same room together! 🥰😂).

Go team! 👊👏

[Ashley Ball-Gamble @ashleysgamble]

Great to see @REFoRMS_Rhabdo represented at #SIOPCongress @WorldSIOP @cclguk @AlicesArc

[REFoRMS Project @REFoRMS_Rhabdo]

Four years ago we introduced the world to the REFoRMS project and what we wanted to achieve!

As it is Childhood Cancer Awareness Month, we thought it would be a great time to reflect on this research project and all that we have done so far! ✅

🎗️#CCAM #rhabdomyosarcoma

[Connor Evans @ConnorJEvans]

Another great project just getting off the ground! If any parents of children/young people with relapsed/refractory #neuroblastoma want to share their experience, we need your help!

Get in touch and find out more about our project from Lucy below! 👇🏼

#CCAM #systematicreview

[Lucy Shepherd @lucy_shepherd29]

We've started a new research project at @crd_york, looking at early phase trials of treatments for children/young people with relapsed and refractory #neuroblastoma, funded by @cclguk! We're looking for parents to help us with the research. Drop me an email/DM for more info ✉️!

[REFoRMS Project @REFoRMS_Rhabdo]

We recently completed the analysis of the qualitative study working with families to understand decision making in relapsed/refractory #rhabdomyosarcoma

A link to the video summarising the findings of this project is below. 👇

https://t.co/xYHoMN9v7X

[CRD - no longer active @crd_york]

We are excited to announce that the newly refreshed #PROSPERO website is now live! The new website offers:
* Improved registration process
* Improved searching functionality
* Faster processing of systematic review protocols

https://t.co/QUFcmQg3NO

[REFoRMS Project @REFoRMS_Rhabdo]

The 5th update for the living-REFoRMS project (LSR-5) is now available to see on the @AlicesArc website!

https://t.co/o1xbnkC7gF

This review has now identified >170 published early phase studies with >1350 children and young people with relapsed/refractory #rhabdomyosarcoma

[CCLG @cclguk]

We have big news! 📣

Children’s Cancer and Leukaemia Group (CCLG) and @TYACancerPro have merged their memberships to form a new professional association.

Introducing CCLG: The Children & Young People’s Cancer Association!

https://t.co/S5jnlcabt5

#CCLG #CYPCancer

[CRD - no longer active @crd_york]

The number of systematic review protocols registered on PROSPERO passes 300,000 - read more on this here: https://t.co/joYrsco6ex

[Connor Evans @ConnorJEvans]

A great short talk by @drjessmorgan explaining what early phase trials are in such a simple way! 👍🏼

[REFoRMS Project @REFoRMS_Rhabdo]

One of our researchers @drjessmorgan recently did a short talk at the @CCLG_UK research discovery day!

She explained what early phase trials are, and how the REFoRMS project is involved in understanding this #research!

Check it out here 👇
https://t.co/tLKuaqnmG1

[CRD - no longer active @crd_york]

How do EndNote and Zotero compare in finding full texts? CRD authors investigated the number of full texts retrieved; unique full texts; differences in versions for the same record; time taken; and accuracy https://t.co/PV8NTcxJ26

#EndNote #Zotero

@HelenFulbright @ConnorJEvans

[CRD - no longer active @crd_york]

You can now register for our upcoming online 'Introduction to Systematic Reviews and Critical Appraisal' course which will be held from 18-29 November 2024.

For details visit: https://t.co/gDKr3V7kTE

[Lucy Shepherd @lucy_shepherd29]

I've learnt so much already from parents of children who have had follow-up scans for #medulloblastoma and #ependymoma.

The study, based at the University of York, is still recruiting and we'd love to hear about your thoughts, feelings and experiences!

[REFoRMS Project @REFoRMS_Rhabdo]

Project update: The 3rd living-reforms update report (LSR-3) is now available to read on the @CCLG_UK website! 😀

https://t.co/lmEmvVopP4

The REFoRMS review has now identified 165 published early phase studies including >1300 CYP with relapsed/refractory #rhabdomyosarcoma

[CRD - no longer active @crd_york]

Research on the road: Paediatric leukaemia surveillance testing - is it worth it? Coming to @CCLG_UK NEXT WEEK!
@drjessmorgan @HolzMelton @ConnorJEvans @CandlelightersT @UniOfYork @UoYResearch
https://t.co/mdwqVakCfK

[Connor Evans @ConnorJEvans]

@sdias_stats Thank you Sofia! 😊

[Connor Evans @ConnorJEvans]

So yesterday I did a thing…

Mr and Mrs Evans
08.04.24
Sandburn Hall, York

The most magical day that I will cherish forever! ❤️ #wedding

[Connor Evans @ConnorJEvans]

@Claire7York Thank you Claire! 😊

[Connor Evans @ConnorJEvans]

Super proud of the team getting this published! 😊

The REFoRMS project is continuing to expand and it is so great to see the engagement and impact this project is having on research into #rhabdomyosarcoma in children!

[REFoRMS Project @REFoRMS_Rhabdo]

📢 The 1st spin-off project from the baseline review has been published!

The Local-REFoRMS paper looking at the use of combined surgery & brachytherapy for children/young people with relapsed/refractory #rhabdomyosarcoma is now available online! 👇

https://t.co/sehUxDN20G